Celestica introduces DS6005 co-packaged optics data-center switch
Celestica announced the liquid-cooled DS6005 CPO Ethernet switch, designed for 102.4 Tb/s scale.
Article subject labels can be suggestions and are not editorial confirmation.
Celestica announced the liquid-cooled DS6005 CPO Ethernet switch, designed for 102.4 Tb/s scale.
The UN migration agency says frontline teams screen travellers and raise awareness as South Sudan prepares for possible Ebola importation; the country had no confirmed case in the report.
WHO Europe and Médecins Sans Frontières began cooperation to improve tuberculosis, drug-resistant TB and HIV services in Eastern Europe and Central Asia.
WHO is expanding its medical-device prequalification programme to include contraceptives and innovative tuberculosis screening technologies.
WHO announced recommended viral components for influenza vaccines intended for the 2027 southern hemisphere season, following an international consultation.
At the second UN General Assembly high-level meeting, countries renewed their call for collective action and equitable investment in preventing, preparing for and responding to future pandemics.
WHO said cholera deaths reported by 47 countries in 2025 reached their highest level since 1999. The release also covered surveillance trends for meningitis and plague.
Nigeria expanded HIV-prevention training to strengthen health workers’ capacity to provide pre-exposure prophylaxis (PrEP).
WHO validated Chile for eliminating dog-transmitted rabies as a public-health problem. Chile is the first country in South America to receive the validation.
HPV9 will join Singapore’s childhood and adult immunisation schedules for eligible females from 1 January 2027. The ministry says covered HPV types are associated with about 90% of cervical cancers.
In the week ending 26 September, clinical laboratories tested 33,547 respiratory specimens and 1,151 were influenza-positive. CDC said national influenza activity remained low but was increasing.
Goa has launched a life-course immunisation policy for 2026–2036. Its initial phase will offer influenza, pneumococcal and hepatitis B vaccines to at-risk adult groups.